>98 %

store at -20℃ for one year（Powder）；
in DMSO or others solvent store at 2-4℃ for two weeks, at -20℃ for six months.

Bay11-7082；BAY11-7082;BAY 11-7082;BAY117082

白色至类白色粉末

DMSO ：41 mg/mL (197.82 mM)

Ethanol ：10 mg/mL (48.25 mM)

E2-conjugating enzymes；IκBα phosphorylation

Bay 11-7082, an inhibitor of NF-κB, induces apoptosis of HTLV-I-infected T-cell lines but only negligible apoptosis of HTLV-I-negative T cells. Bay 11-7082 rapidly and efficiently reduces the DNA binding of NF-κB in HTLV-I-infected T-cell lines and down-regulated the expression of the antiapoptotic gene, Bcl-xL, regulated by NF-κB. Bay 11-7082 selectively inhibits Tax-induced NF-κB activity in a human T-cell line. BAY 11-7082 inhibits NFκB signalling and is recently shown to inhibit the majority of E2 and E3 ligases tested by reacting covalently with the catalytic cysteine residues. Moreover, BAY 11-7082 also inhibits several tyrosine phosphatases by reacting with catalytic Cys residue of these enzymes. NSC 697923 is originally shown to inhibit the E2 ligase Ubc13-Uev1A. BAY 11-7082 inhibits the phosphorylation of IκBα and activation of NF-κB, induces the death of HBL-1 cells. BAY 11-7082 completely suppresses the LPS-stimulated and IL-1-stimulated phosphorylation of the activation loop of IKKβ. BAY 11-7082 acts by inhibiting TNF-α-induced phosphorylation of IκB-α, resulting in decreased NF-κB and decreases expression of adhesion molecules.

[1] Melisi D, et al. Expert Opin Ther Targets, 2007, 11(2), 133-144.
[2] Gastonguay A, et al. Cancer Biol Ther, 2012, 13(8), 647-656.
[3] Miwatashi S, et al. J Med Chem, 2005, 48(19), 5966-5979.
[4] Mori N, et al. Blood, 2002, 100(5), 1828-1834.
[5] Goffi F, et al. Neurosci Lett, 2005, 377(3), 147-151.
[6] Strickson S, et al. Biochem J. 2013, 451(3), 427-437.